In vitro analysis of the release of incorporated agents from sodium caseinate microspheres

References

• Aulron M. E. Pharmaceutics. The Science of Dosage Form Design. Churchill Livingstone. 1988; 76
   Google Scholar
• Bogdansky S. Natural polymers as drug delivery systems. Biodegradable Polymers as Drug Delivery Systems, M. Chasin, R. Langer. Marcel Dekker Inc., New York 1990; Vol 45: 231–259, From: Drugs and the Pharmaceutical Sciences, series editor: J. Swarbrick
   Google Scholar
• Chen Y., Willmott N., Anderson J., Florence A. T. Comparison of albumin and casein microspheres as a carrier for doxorubicin. Journal of Pharmacy and Pharmacology 1987; 39: 978–985
   PubMed Web of Science ®Google Scholar
• Cummings J., Willmott N., Marley E., Smyth J. Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition. Biochemical Pharmacology 1991; 41: 1849–1854
   PubMed Web of Science ®Google Scholar
• Desoize B., Jardillier J. C., Kanoun K., GuÉrin D., Lévy M.-C. In vitro cytotoxic acitivity of cross-linked protein microcapsules. Journal of Pharmacy and Pharmacology 1986; 38: 8–13
   PubMed Web of Science ®Google Scholar
• Gupta P. K., Hung C. T., Perrier D. G. Albumin microspheres. I. Release characteristics of adriamycin. International Journal of Pharmaceutics 1986; 33: 137–146
   Web of Science ®Google Scholar
• Higuchi T. Rates of release of medicaments from ointment bases containing drugs in suspension. Journal of Pharmaceutical Sciences 1961; 50: 874–875
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained-action medication. Journal of Pharmaceutical Sciences 1963; 52: 1145–1149
   PubMed Web of Science ®Google Scholar
• Jayakrishnan A., Knepp W. A., Goldberg E. P. Casein microspheres: preparation and evaluation as a carrier for controlled drug delivery. International Journal of Pharmaceutics 1994; 106: 221–228
   Web of Science ®Google Scholar
• Knepp W. A., Jayakrishnan A., Quigg J. M., Sitren H. S., Bagnall J. J., Goldberg E. P. Synthesis, properties and intratumoral evaluation of mitoxantrone-loaded casein microspheres in Lewis Lung Carcinoma. Journal of Pharmacy and Pharma cology 1993; 45: 887–891
   PubMed Web of Science ®Google Scholar
• Kramer P. A. Albumin microspheres as vehicles for achieving specificity in drug delivery. Journal of Pharmaceutical Sciences 1974; 63: 1616–1617
   Web of Science ®Google Scholar
• Latha M. S., Jayakrishnan A. Glutaraldehyde cross-linked bovine casein microspheres as a matrix for the controlled release of theophylline: In vitro studies. Journal of Pharmacy and Pharmacology 1994; 46: 8–13
   PubMed Web of Science ®Google Scholar
• Lévy M.-C., Guérin D. Microcapsules préparées par réticulation interfaciale des protéines du lait. Pharmaceutica Acta Helvetica 1987; 62: 236–240
   PubMedGoogle Scholar
• Malvern Series 2600-user manual. Malvern Instruments Ltd., Malvern, WorcsUK
   Google Scholar
• Millar F. C. Physicochemical investigations of caseins as pharmaceutical excipients in solid dosage forms. University of Dublin, Trinity College. 1991, Ph.D. thesis
   Google Scholar
• Minsq: Nonlinear Parameter Estimation and Model Development. MicroMath Scientific Software. Salt Lake City 1988, Utah 84121
   Google Scholar
• Oppenheim R. C., Marty J. J., Speiser P. Injectable compositions, nanoparticles useful therein, and process of manufacturing same. US Patent 4,107,288, 1978
   Google Scholar
• Orienti I., Zecchi V. Progresterone-loaded albumin microparticles. Journal of Controlled Release 1993; 27: 1–7
   Web of Science ®Google Scholar
• Quigg J. M., Knepp W. A., Jayakrishnan A., Sitren H. S., Bagnall J. J., Mentak K., Farnworth S. T., Yahiaoui A., Goldberg E. P. Synthesis, properties and intratumoural evaluation of drug loaded protein microspheres. Proceedings of the International Symposium on Controlled Release of Bioactive Materials 1992; 19: 156–157
   Google Scholar
• Ritger P. L., Peppas N. A. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders and discs. Journal of Controlled Release 1987; 5: 23–36
   Google Scholar
• Sinclair G. W., Peppas N. A. Analysis of non-Fickian transport in polymers using simplified exponential expressions. Journa1 of Membrane Science 1984; 17: 329–331
   Web of Science ®Google Scholar
• Tomlinson E., Burger J. J., Schoonderwoerd E. M. A., McVie J. G. Human serum albumin microspheres for intra-arterial drug targeting of cytostatic compounds. Microspheres and Drug Therapy, Pharmaceutical, Immunological and Medical Aspects, S. S. Davis, L. Illum, J. G. McVie, E. Tomlinson. Elsevier, Amseterdam 1984; 75–89
   Google Scholar
• Washington C. Drug release from microdisperse systems: a critical review. International Journal of Pharmaceutics 1990; 58: 1–12
   Web of Science ®Google Scholar
• Willmott N., Chen Y., Goldberg J., McArdle C., Florence A. T. Biodegradation rate of embolized protein microspheres in lung, liver and kidney of rats. Journal of Pharmacy and Pharmacology 1989; 41: 433–438
   PubMed Web of Science ®Google Scholar
• Willmott N., Cummings J., Florence A. T. In vitro release of adriamycin from drug-loaded albumin and haemoglobin microspheres. Journal of Microen-capsulation 1985b; 2: 293–304
   PubMedGoogle Scholar
• Willmott N., Goldberg J. A., Chen Y., McArdle C., Florence A. T. In vivo distribution and fate of protein microspheres in the rat. British Journal of Cancer 1985a; 59: 828
   Google Scholar
• Willmott N., Magee G. A., Cummings J., Halbert G. W., Smyth J. F. Doxorubicin-loaded casein microspheres: protean nature of drug incorporation. Journal of Pharmacy and Pharmacology 1992; 44: 472–475
   PubMed Web of Science ®Google Scholar
• Zolle I., Rhodes B. A., Wagner H. N., Jr. Preparation of metabolisable radioactive human serum albumin microspheres for studies of the circulation. International Journal of Applied Radiation and Isotopes 1970; 21: 155–167
   PubMedGoogle Scholar